HIGHLIGHTS
- who: Dominik Thor et al. from the Tomorrowlabs GmbH, Vienna, Austria Department of Dermatology and Allergology, University Hospital Aachen, Aachen, Germany have published the research: A Novel Hair Restoration Technology Counteracts Androgenic Hair Loss and Promotes Hair Growth in A Blinded Clinical Trial, in the Journal: (JOURNAL)
- what: The authors aim to demonstrate the positive influence of Tomorrowlabs HIF strengthening factor on biology in monocentric blinded clinical trial over total period of 9 months. trial with 20 subjects (4 female and 16 male) and once-daily application of_[HSF] to the scalp was conducted. According . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.